Interpretation of NOTCH3 mutations in the diagnosis of CADASIL

References

• Tournier-Lasserve E, Iba-Zizen MT, Romero N, Bousser MG. Autosomal dominant syndrome with strokelike episodes and leukoencephalopathy. Stroke 1991;22:1297-302
   PubMed Web of Science ®Google Scholar
• Baudrimont M, Dubas F, Joutel A, et al. Autosomal dominant leukoencephalopathy and subcortical ischemic stroke. A clinicopathological study. Stroke 1993;24:122-5
   PubMed Web of Science ®Google Scholar
• Chabriat H, Vahedi K, Iba-Zizen MT, et al. Clinical spectrum of CADASIL: a study of 7 families. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Lancet 1995;346:934-9
   PubMed Web of Science ®Google Scholar
• Joutel A, Corpechot C, Ducros A, et al. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 1996;383:707-10
   PubMed Web of Science ®Google Scholar
• Narayan SK, Gorman G, Kalaria RN, et al. The minimum prevalence of CADASIL in northeast England. Neurology 2012;78:1025-7
   Google Scholar
• Kalimo H, Ruchoux MM, Viitanen M, Kalaria RN. CADASIL: a common form of hereditary arteriopathy causing brain infarcts and dementia. Brain Pathol 2002;12:371-84
   PubMed Web of Science ®Google Scholar
• Razvi SS, Davidson R, Bone I, Muir KW. The prevalence of cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL) in the west of Scotland. J Neurol Neurosurg Psychiatry 2005;76:739-41
   PubMed Web of Science ®Google Scholar
• Joutel A, Favrole P, Labauge P, et al. Skin biopsy immunostaining with a Notch3 monoclonal antibody for CADASIL diagnosis. Lancet 2001;358:2049-51
   PubMed Web of Science ®Google Scholar
• Ruchoux MM, Guerouaou D, Vandenhaute B, et al. Systemic vascular smooth muscle cell impairment in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Acta Neuropathol 1995;89:500-12
   PubMed Web of Science ®Google Scholar
• Joutel A, Andreux F, Gaulis S, et al. The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients. J Clin Invest 2000;105:597-605
   PubMed Web of Science ®Google Scholar
• Domenga V, Fardoux P, Lacombe P, et al. A Notch3 is required for arterial identity and maturation of vascular smooth muscle cells. Genes Dev 2004;18:2730-5
   PubMed Web of Science ®Google Scholar
• Wang T, Baron M, Trump D. An overview of Notch3 function in vascular smooth muscle cells. Prog Biophys Mol Biol 2008;96:499-509
   PubMed Web of Science ®Google Scholar
• Joutel A, Vahedi K, Corpechot C, et al. Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients. Lancet 1997;350:1511-15
   PubMed Web of Science ®Google Scholar
• Dichgans M, Ludwig H, Muller-Hocker J, et al. Small in-frame deletions and missense mutations in CADASIL: 3D models predict misfolding of Notch3 EGF-like repeat domains. Eur J Hum Genet 2000;8:280-5
   PubMedGoogle Scholar
• Duering M, Karpinska A, Rosner S, et al. Co-aggregate formation of CADASIL-mutant NOTCH3: a single-particle analysis. Hum Mol Genet 2011 20(16):3256-65
   Google Scholar
• Monet-Lepretre M, Haddad I, Baron-Menguy C, et al. Abnormal recruitment of extracellular matrix proteins by excess Notch3ECD: a new pathomechanism in CADASIL. Brain 2013;136:1830-45
   Google Scholar
• Ruchoux MM, Chabriat H, Bousser MG, et al. Presence of ultrastructural arterial lesions in muscle and skin vessels of patients with CADASIL. Stroke 1994;25:2291-2
   PubMed Web of Science ®Google Scholar
• Chabriat H, Joutel A, Dichgans M, et al. Cadasil. Lancet Neurol 2009;8:643-53
   PubMed Web of Science ®Google Scholar
• Kalaria RN, Kalimo H. Introduction: non-atherosclerotic cerebrovascular disorders. Brain Pathol 2002;12:337-42
   Google Scholar
• Miao Q, Paloneva T, Tuominen S, et al. Fibrosis and stenosis of the long penetrating cerebral arteries: the cause of the white matter pathology in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Brain Pathol 2004;14:358-64
   PubMed Web of Science ®Google Scholar
• Chabriat H, Pappata S, Ostergaard L, et al. Cerebral hemodynamics in CADASIL before and after acetazolamide challenge assessed with MRI bolus tracking. Stroke 2000;31:1904-12
   PubMed Web of Science ®Google Scholar
• Pfefferkorn T, von Stuckrad-Barre S, Herzog J, et al. Reduced cerebrovascular CO(2) reactivity in CADASIL: a transcranial Doppler sonography study. Stroke 2001;32:17-21
   PubMed Web of Science ®Google Scholar
• Tuominen S, Miao Q, Kurki T, et al. Positron emission tomography examination of cerebral blood flow and glucose metabolism in young CADASIL patients. Stroke 2004;35:1063-7
   PubMed Web of Science ®Google Scholar
• Dichgans M, Mayer M, Uttner I, et al. The phenotypic spectrum of CADASIL: clinical findings in 102 cases. Ann Neurol 1998;44:731-9
   PubMed Web of Science ®Google Scholar
• Opherk C, Peters N, Herzog J, et al. Long-term prognosis and causes of death in CADASIL: a retrospective study in 411 patients. Brain 2004;127:2533-9
   PubMed Web of Science ®Google Scholar
• Desmond DW, Moroney JT, Lynch T, et al. The natural history of CADASIL: a pooled analysis of previously published cases. Stroke 1999;30:1230-3
   PubMed Web of Science ®Google Scholar
• Adib-Samii P, Brice G, Martin RJ, Markus HS. Clinical spectrum of CADASIL and the effect of cardiovascular risk factors on phenotype: study in 200 consecutively recruited individuals. Stroke 2010;41:630-4
   PubMed Web of Science ®Google Scholar
• Peters N, Opherk C, Danek A, et al. The pattern of cognitive performance in CADASIL: a monogenic condition leading to subcortical ischemic vascular dementia. Am J Psychiatry 2005;162:2078-85
   PubMed Web of Science ®Google Scholar
• Buffon F, Porcher R, Hernandez K, et al. Cognitive profile in CADASIL. J Neurol Neurosurg Psychiatry 2006;77:175-80
   PubMed Web of Science ®Google Scholar
• Amberla K, Waljas M, Tuominen S, et al. Insidious cognitive decline in CADASIL. Stroke 2004;35:1598-602
   PubMed Web of Science ®Google Scholar
• Roine S, Poyhonen M, Timonen S, et al. Neurologic symptoms are common during gestation and puerperium in CADASIL. Neurology 2005;64:1441-3
   PubMed Web of Science ®Google Scholar
• Reyes S, Viswanathan A, Godin O, et al. Apathy: a major symptom in CADASIL. Neurology 2009;72:905-10
   PubMed Web of Science ®Google Scholar
• Haan J, Lesnik Oberstein SA, Ferrari MD. Epilepsy in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Cerebrovasc Dis 2007;24:316-17
   PubMedGoogle Scholar
• Feuerhake F, Volk B, Ostertag CB, et al. Reversible coma with raised intracranial pressure: an unusual clinical manifestation of CADASIL. Acta Neuropathol 2002;103:188-92
   PubMedGoogle Scholar
• Schon F, Martin RJ, Prevett M, et al. "CADASIL coma": an underdiagnosed acute encephalopathy. J Neurol Neurosurg Psychiatry 2003;74:249-52
   PubMedGoogle Scholar
• Ragno M, Pianese L, Morroni M, et al. "CADASIL coma" in an Italian homozygous CADASIL patient: comparison with clinical and MRI findings in age-matched heterozygous patients with the same G528C NOTCH3 mutation. Neurol Sci 2013;34(11):1947-53
   Google Scholar
• Chabriat H, Levy C, Taillia H, et al. Patterns of MRI lesions in CADASIL. Neurology 1998;51:452-7
   PubMed Web of Science ®Google Scholar
• Skehan SJ, Hutchinson M, MacErlaine DP. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: MR findings. AJNR Am J Neuroradiol 1995;16:2115-19
   Web of Science ®Google Scholar
• Auer DP, Putz B, Gossl C, et al. Differential lesion patterns in CADASIL and sporadic subcortical arteriosclerotic encephalopathy: MR imaging study with statistical parametric group comparison. Radiology 2001;218:443-51
   Web of Science ®Google Scholar
• Lesnik Oberstein SA, van den Boom R, van Buchem MA, et al. Cerebral microbleeds in CADASIL. Neurology 2001;57:1066-70
   PubMed Web of Science ®Google Scholar
• Dichgans M, Holtmannspotter M, Herzog J, et al. Cerebral microbleeds in CADASIL: a gradient-echo magnetic resonance imaging and autopsy study. Stroke 2002;33:67-71
   PubMed Web of Science ®Google Scholar
• van Den BR, Lesnik Oberstein SA, van Duinen SG, et al. Subcortical lacunar lesions: an MR imaging finding in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Radiology 2002;224:791-6
   Google Scholar
• Wang Z, Yuan Y, Zhang W, et al. NOTCH3 mutations and clinical features in 33 mainland Chinese families with CADASIL. J Neurol Neurosurg Psychiatry 2011;82:534-9
   PubMed Web of Science ®Google Scholar
• Phillips CD, Zuckerman SJ. CADASIL can mimic multiple sclerosis. J La State Med Soc 2010;162:174
   PubMedGoogle Scholar
• Razvi SS, Davidson R, Bone I, Muir KW. Is inadequate family history a barrier to diagnosis in CADASIL? Acta Neurol Scand 2005;112:323-6
   Google Scholar
• Coto E, Menendez M, Navarro R, et al. A new de novo Notch3 mutation causing CADASIL. Eur J Neurol 2006;13:628-31
   Google Scholar
• Joutel A, Dodick DD, Parisi JE, et al. De novo mutation in the Notch3 gene causing CADASIL. Ann Neurol 2000;47:388-91
   PubMed Web of Science ®Google Scholar
• Lesnik Oberstein SA, van Duinen SG, van den Boom R, et al. Evaluation of diagnostic NOTCH3 immunostaining in CADASIL. Acta Neuropathol 2003;106:107-11
   PubMed Web of Science ®Google Scholar
• Ebke M, Dichgans M, Bergmann M, et al. CADASIL: skin biopsy allows diagnosis in early stages. Acta Neurol Scand 1997;95:351-7
   PubMed Web of Science ®Google Scholar
• Mayer M, Straube A, Bruening R, et al. Muscle and skin biopsies are a sensitive diagnostic tool in the diagnosis of CADASIL. J Neurol 1999;246:526-32
   PubMed Web of Science ®Google Scholar
• Tikka S, Mykkanen K, Ruchoux MM, et al. Congruence between NOTCH3 mutations and GOM in 131 CADASIL patients. Brain 2009;132:933-9
   PubMed Web of Science ®Google Scholar
• Morroni M, Marzioni D, Ragno M, et al. Role of electron microscopy in the diagnosis of cadasil syndrome: a study of 32 patients. PLoS One 2013;8:e65482
   Google Scholar
• Markus HS, Martin RJ, Simpson MA, et al. Diagnostic strategies in CADASIL. Neurology 2002;59:1134-8
   PubMed Web of Science ®Google Scholar
• Malandrini A, Gaudiano C, Gambelli S, et al. Diagnostic value of ultrastructural skin biopsy studies in CADASIL. Neurology 2007;68:1430-2
   PubMed Web of Science ®Google Scholar
• Peters N, Opherk C, Bergmann T, et al. Spectrum of mutations in biopsy-proven CADASIL: implications for diagnostic strategies. Arch Neurol 2005;62:1091-4
   PubMed Web of Science ®Google Scholar
• Oberstein SA. Diagnostic strategies in CADASIL. Neurology 2003;60:2020
   Google Scholar
• Arboleda-Velasquez JF, Lopera F, Lopez E, et al. C455R notch3 mutation in a Colombian CADASIL kindred with early onset of stroke. Neurology 2002;59:277-9
   Google Scholar
• Singhal S, Bevan S, Barrick T, et al. The influence of genetic and cardiovascular risk factors on the CADASIL phenotype. Brain 2004;127:2031-8
   PubMed Web of Science ®Google Scholar
• Dichgans M, Filippi M, Bruning R, et al. Quantitative MRI in CADASIL: correlation with disability and cognitive performance. Neurology 1999;52:1361-7
   PubMed Web of Science ®Google Scholar
• Mykkanen K, Junna M, Amberla K, et al. Different clinical phenotypes in monozygotic CADASIL twins with a novel NOTCH3 mutation. Stroke 2009;40:2215-18
   PubMed Web of Science ®Google Scholar
• Liem MK, Lesnik Oberstein SA, Vollebregt MJ, et al. Homozygosity for a NOTCH3 mutation in a 65-year-old CADASIL patient with mild symptoms: a family report. J Neurol 2008;255:1978-80
   Google Scholar
• Tuominen S, Juvonen V, Amberla K, et al. Phenotype of a homozygous CADASIL patient in comparison to 9 age-matched heterozygous patients with the same R133C Notch3 mutation. Stroke 2001;32:1767-74
   Google Scholar
• Soong BW, Liao YC, Tu PH, et al. A homozygous NOTCH3 mutation p.R544C and a heterozygous TREX1 variant p.C99MfsX3 in a family with hereditary small vessel disease of the brain. J Chin Med Assoc 2013;76:319-24
   Google Scholar
• Vinciguerra C, Rufa A, Bianchi S, et al. Homozygosity and severity of phenotypic presentation in a CADASIL family. Neurol Sci 2014;35(1):91-3
   Google Scholar
• Rutten JW, Boon EM, Liem MK, et al. Hypomorphic NOTCH3 alleles do not cause cadasil in humans. Hum Mutat 2013;34:1486-9
   Google Scholar
• Mazzei R, Guidetti D, Ungaro C, et al. First evidence of a pathogenic insertion in the NOTCH3 gene causing CADASIL. J Neurol Neurosurg Psychiatry 2008;79:108-10
   Google Scholar
• Joutel A, Chabriat H, Vahedi K, et al. Splice site mutation causing a seven amino acid Notch3 in-frame deletion in CADASIL. Neurology 2000;54:1874-5
   Google Scholar
• Dichgans M, Herzog J, Gasser T. NOTCH3 mutation involving three cysteine residues in a family with typical CADASIL. Neurology 2001;57:1714-17
   Google Scholar
• Lee SJ, Meng H, Elmadhoun O, et al. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy affecting an African American man: identification of a novel 15-base pair NOTCH3 duplication. Arch Neurol 2011;68:1584-6
   Google Scholar
• Saiki S, Sakai K, Saiki M, et al. Varicose veins associated with CADASIL result from a novel mutation in the Notch3 gene. Neurology 2006;67:337-9
   PubMedGoogle Scholar
• Lackovic V, Bajcetic M, Lackovic M, et al. Skin and sural nerve biopsies: ultrastructural findings in the first genetically confirmed cases of CADASIL in Serbia. Ultrastruct Pathol 2012;36:325-35
   PubMed Web of Science ®Google Scholar
• Mazzei R, Conforti FL, Lanza PL, et al. A novel Notch3 gene mutation not involving a cysteine residue in an Italian family with CADASIL. Neurology 2004;63:561-4
   Google Scholar
• Bianchi S, Dotti MT, Gallus GN, et al. First deep intronic mutation in the NOTCH3 gene in a family with late-onset CADASIL. Neurobiol Aging 2013;34:2234-12
   Google Scholar
• Mizuno T, Muranishi M, Torugun T, et al. Two Japanese CADASIL families exhibiting Notch3 mutation R75P not involving cysteine residue. Intern Med 2008;47:2067-72
   Google Scholar
• Ampuero I, Alegre-Abarrategui J, Rodal I, et al. On the diagnosis of CADASIL. J Alzheimers Dis 2009;17:787-94
   Google Scholar
• Roy B, Maksemous N, Smith RA, et al. Two novel mutations and a previously unreported intronic polymorphism in the NOTCH3 gene. Mutat Res 2012;732:3-8
   Google Scholar
• Kotorii S, Takahashi K, Kamimura K, et al. Mutations of the notch3 gene in non-Caucasian patients with suspected CADASIL syndrome. Dement Geriatr Cogn Disord 2001;12:185-93
   Google Scholar
• Uchino M, Hirano T, Uyama E, Hashimoto Y. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) and CADASIL-like disorders in Japan. Ann NY Acad Sci 2002;977:273-8
   Google Scholar
• Ferreira S, Malheiro F, Oliveira JP. Novel human pathological mutations. Gene symbol: NOTCH3. Disease: cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Hum Genet 2007;121:651-2
   Google Scholar
• Ferreira S, Fontoura P, Guerreiro R, Oliveira JP. Novel human pathological mutations. Gene symbol: NOTCH3. Disease: cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL). Hum Genet 2007;121:649-50
   Google Scholar
• Scheid R, Heinritz W, Leyhe T, et al. Cysteine-sparing notch3 mutations: cadasil or cadasil variants? Neurology 2008;71:774-6
   Google Scholar
• Ungaro C, Mazzei R, Conforti FL, et al. CADASIL: extended polymorphisms and mutational analysis of the NOTCH3 gene. J Neurosci Res 2009;87:1162-7
   PubMed Web of Science ®Google Scholar
• Quattrone A, Mazzei R. Cysteine-sparing notch3 mutations: cadasil or cadasil variants? Neurology 2009;72:2135-6
   Google Scholar
• Brass SD, Smith EE, Arboleda-Velasquez JF, et al. Case records of the Massachusetts General Hospital. Case 12-2009. A 46-year-old man with migraine, aphasia, and hemiparesis and similarly affected family members. N Engl J Med 2009;360:1656-65
   Google Scholar
• Kim Y, Choi EJ, Choi CG, et al. Characteristics of CADASIL in Korea: a novel cysteine-sparing Notch3 mutation. Neurology 2006;66:1511-16
   Google Scholar
• Kim YE, Yoon CW, Seo SW, et al. Spectrum of NOTCH3 mutations in Korean patients with clinically suspicious cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Neurobiol Aging 2014;35:726
   Google Scholar
• Dotti MT, De SN, Bianchi S, et al. A novel NOTCH3 frameshift deletion and mitochondrial abnormalities in a patient with CADASIL. Arch Neurol 2004;61:942-5
   PubMedGoogle Scholar
• Weiming F, Yuliang W, Youjie L, et al. A novel Notch3 deletion mutation in a Chinese patient with cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL). J Clin Neurosci 2013;20:322-3
   Google Scholar
• Cognat E, Baron-Menguy C, Domenga-Denier V, et al. Archetypal Arg169Cys mutation in NOTCH3 does not drive the pathogenesis in cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy via a loss-of-function mechanism. Stroke 2014;45(3):842-9
   Google Scholar
• Fouillade C, Chabriat H, Riant F, et al. Activating NOTCH3 mutation in a patient with small-vessel-disease of the brain. Hum Mutat 2008;29:452
   PubMed Web of Science ®Google Scholar
• Martignetti JA, Tian L, Li D, et al. Mutations in PDGFRB cause autosomal-dominant infantile myofibromatosis. Am J Hum Genet 2013;92:1001-7
   Google Scholar
• Bersano A, Ranieri M, Ciammola A, et al. Considerations on a mutation in the NOTCH3 gene sparing a cysteine residue: a rare polymorphism rather than a CADASIL variant. Funct Neurol 2012;27:247-52
   Google Scholar
• den Dunnen JT, Antonarakis SE. Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat 2000;15:7-12
   PubMed Web of Science ®Google Scholar
• Ross OA, Soto-Ortolaza AI, Heckman MG, et al. NOTCH3 Variants and Risk of Ischemic Stroke. PLoS One 2013;8:e75035
   PubMed Web of Science ®Google Scholar
• Schmidt H, Zeginigg M, Wiltgen M, et al. Genetic variants of the NOTCH3 gene in the elderly and magnetic resonance imaging correlates of age-related cerebral small vessel disease. Brain 2011;134:3384-97
   Google Scholar